Sun Pharma Wins Generic Semaglutide Nod in South Africa, Stock Hits 52-Week High

SAHPRA approval marks an emerging-market beachhead for generic Ozempic, but limited geographic scope and patent walls in US/EU cap near-term revenue upside despite bullish sentiment.

ndtv-profit-business · 7/15/2026, 6:33:19 AM · Ask about this →